A single‐chain variable fragment‐anticancer lytic peptide (scFv‐ACLP) fusion protein for targeted cancer treatment.

Autor: Zhang, Rui1 (AUTHOR), Pei, Pengfei1 (AUTHOR), Wang, Yifan1 (AUTHOR), Guo, Quanqiang1 (AUTHOR), Luo, Shi‐Zhong1 (AUTHOR), Chen, Long1 (AUTHOR) chenlong@mail.buct.edu.cn
Zdroj: Chemical Biology & Drug Design. Jun2023, Vol. 101 Issue 6, p1406-1415. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje